Navigation Links
Cephalon's 2007 Results Exceed Full Year Sales and Earnings Guidance
Date:2/12/2008

199,407 40,665 240,072

Generic OTFC 129,033 - 129,033

FENTORA 135,136 - 135,136

AMRIX 8,401 - 8,401

Pain 471,977 40,665 512,642

Other 69,263 236,037 305,300

$1,393,521 $333,778 $1,727,299

Year Ended

December 31,

2006

United

States Europe Total

Sales:

PROVIGIL $684,885 $43,052 $727,937

GABITRIL 54,096 4,316 58,412

CNS 738,981 47,368 786,349

ACTIQ 544,886 27,252 572,138

Generic OTFC 54,801 - 54,801

FENTORA 29,250 - 29,250

AMRIX - - -

Pain 628,937 27,252 656,189

Other 56,084 208,277 264,361

$1,424,002 $282,897 $1,706,899

%

Increase

(Decrease)

United

States Europe Total

Sales:

PROVIGIL 17% 17% 17%

GABITRIL (6%) 54% (2%)


'/>"/>

SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
4. CNS Response Announces Fiscal Third Quarter 2007 Results
5. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
8. Carrington Reports Second Quarter 2007 Results
9. Avitar Reports Third Quarter Financial Results for Fiscal 2007
10. Response Genetics Reports Second Quarter 2007 Financial Results
11. Martek to Announce Third Quarter 2007 Results on September 5, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...ire/ -- MedImmune today announced that,it has ini...hronic asthma to,determine the safety of subcutan...Ab) that targets the interleukin-5 receptor (IL-5R...L-5R pathway may lead to a targeted approach for,...d study of this antibody. , "Asthma can be ...
(Date:12/4/2008)...08 and Full Year 2009 Earnings Guidance , , ...all/ -- DuPont, (NYSE: DD ) today announced fur...and strengthen the company,s competitiveness in 20...low, and provided earnings guidance for the fourth... steep global decline in construction and motor ve...
(Date:12/4/2008)...-- Parion Sciences, Inc. today announced,that its...nitiated a Phase I,clinical trial of GS9411 in he...ability of the investigational compound. GS9411 i...reatment of pulmonary disease. Previously known a...ENaC) blocker discovered by,Parion, a privately h...
(Date:12/4/2008)...rstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ,...used on endocrine therapy and oncology, today anno...h.D., will take part in a panel discussion titled,...nts" at the upcoming RBC Capital Markets 2008 Heal...at 4:30 pm (eastern time) at the Westin Times Squa...
Breaking Biology Technology:MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor 2MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor 3DuPont Takes Aggressive Actions to Strengthen Competitiveness and Increase Cash Flow 2DuPont Takes Aggressive Actions to Strengthen Competitiveness and Increase Cash Flow 3DuPont Takes Aggressive Actions to Strengthen Competitiveness and Increase Cash Flow 4DuPont Takes Aggressive Actions to Strengthen Competitiveness and Increase Cash Flow 5DuPont Takes Aggressive Actions to Strengthen Competitiveness and Increase Cash Flow 6Parion Sciences Announces Initiation of Phase I Clinical Trial to Evaluate Safety and Tolerability of GS9411 2Parion Sciences Announces Initiation of Phase I Clinical Trial to Evaluate Safety and Tolerability of GS9411 3
...d David Batey, Ph.D. , MJ Research, Inc....bstract , We present a real-time quanti... and quantitation of soy genetically modified...osate. The assay utilizes SYBR Green I (SGI) detec...dified organism (GMO) specific sequences as well ,...
...DNA Tissue Kit , Catalog #732-6343, ...affinization , 1. Place 510 mg (0.0050...., tube. Add 300 l xylene and incubate 5 m...ture. , 2. Centrifuge at 13,00016,000 x g ...d the xylene. , 3. Repeat steps 1 and 2 tw...
...ller, Theresa Redila-Flores, Dan Chu, and,Asmita... As the number of diseases and disorders linked t...nning single-base mutations becomes ever more vita...-risk predictor mutations and their , out..., a number of methods , that are faster a...
...*, H.-L. Malinen*, V.-P. Jaakola** and , ...logy Laboratory, REDEC of Kajaani, University of O... ** Department of Biological and Environmental... FIN-40351 Jyvskyl, Finland , , ...#946;LG) is a major whey protein found in the milk...
Other Biology Technology:Detection of Genetically Modified Soybean in Processed Foods Using Real-Time Quantitative PCR with SYBR Green I Dye on the DNA Engine Opticon 2 System 2Detection of Genetically Modified Soybean in Processed Foods Using Real-Time Quantitative PCR with SYBR Green I Dye on the DNA Engine Opticon 2 System 3Detection of Genetically Modified Soybean in Processed Foods Using Real-Time Quantitative PCR with SYBR Green I Dye on the DNA Engine Opticon 2 System 4Detection of Genetically Modified Soybean in Processed Foods Using Real-Time Quantitative PCR with SYBR Green I Dye on the DNA Engine Opticon 2 System 5Detection of Genetically Modified Soybean in Processed Foods Using Real-Time Quantitative PCR with SYBR Green I Dye on the DNA Engine Opticon 2 System 6Detection of Genetically Modified Soybean in Processed Foods Using Real-Time Quantitative PCR with SYBR Green I Dye on the DNA Engine Opticon 2 System 7Detection of Genetically Modified Soybean in Processed Foods Using Real-Time Quantitative PCR with SYBR Green I Dye on the DNA Engine Opticon 2 System 8DNA Isolation From 50 to 20 mg of Paraffin-Embedded Tissue 2Temporal Temperature Gradient Electrophoresis: A Powerful Technique to Screen Mutations 2Temporal Temperature Gradient Electrophoresis: A Powerful Technique to Screen Mutations 3Temporal Temperature Gradient Electrophoresis: A Powerful Technique to Screen Mutations 4Temporal Temperature Gradient Electrophoresis: A Powerful Technique to Screen Mutations 5Temporal Temperature Gradient Electrophoresis: A Powerful Technique to Screen Mutations 6Temporal Temperature Gradient Electrophoresis: A Powerful Technique to Screen Mutations 7Purification and Characterization of beta-Lactoglobulin Genetic Variants A and B Using Preparative Electrophoresis and Isoelectric Focusing 2Purification and Characterization of beta-Lactoglobulin Genetic Variants A and B Using Preparative Electrophoresis and Isoelectric Focusing 3Purification and Characterization of beta-Lactoglobulin Genetic Variants A and B Using Preparative Electrophoresis and Isoelectric Focusing 4Purification and Characterization of beta-Lactoglobulin Genetic Variants A and B Using Preparative Electrophoresis and Isoelectric Focusing 5Purification and Characterization of beta-Lactoglobulin Genetic Variants A and B Using Preparative Electrophoresis and Isoelectric Focusing 6Purification and Characterization of beta-Lactoglobulin Genetic Variants A and B Using Preparative Electrophoresis and Isoelectric Focusing 7Purification and Characterization of beta-Lactoglobulin Genetic Variants A and B Using Preparative Electrophoresis and Isoelectric Focusing 8Purification and Characterization of beta-Lactoglobulin Genetic Variants A and B Using Preparative Electrophoresis and Isoelectric Focusing 9Purification and Characterization of beta-Lactoglobulin Genetic Variants A and B Using Preparative Electrophoresis and Isoelectric Focusing 10Purification and Characterization of beta-Lactoglobulin Genetic Variants A and B Using Preparative Electrophoresis and Isoelectric Focusing 11Purification and Characterization of beta-Lactoglobulin Genetic Variants A and B Using Preparative Electrophoresis and Isoelectric Focusing 12
(Date:12/5/2008)...ne fifth of the standard dose of a commonly used m... full dose. This new finding should allow scarce v...ly during epidemics in Africa. , In a study init... together with Epicentre (the research arm of Doct...barara University of Science and Technology in Uga...
(Date:12/5/2008)...he Stowers Institute,s Baumann Lab has discovered ...omerase, the enzyme that replenishes the sequences...division. The findings were published today in the...merase is viewed as a promising cancer treatment t...cer cells. In order to identify small molecules th...
(Date:12/5/2008)...ASHINGTON, DCOn Tuesday, November 25, 2008, the O...enter gathered experts from many disciplines to sh...promise of prevention and intervention strategies ...f Columbia and nationwide. , Through the Obesity...ildhood obesity using a multidisciplinary approach...
(Date:12/4/2008)... New Rochelle, NY, December 4, 2008Researchers ar...inase (PI3-kinase) pathway as studies continue to ...suppresses tumor growth, reports Genetic Engineer...involved in angiogenesis, cell growth, differentia... PI3/AKT/mTOR pathway, which plays a key role in c...
Breaking Biology News(10 mins):Stowers Institute's Baumann Lab identifies key step in maturation pathway of telomerase 2Children's National convenes first childhood obesity symposium 2Children's National convenes first childhood obesity symposium 3Children's National convenes first childhood obesity symposium 4Bright Starts 28TM 29 Adds New Twist to Old Favorites 23441 1Bright Starts 28TM 29 Adds New Twist to Old Favorites 23441 2Bright Starts 28TM 29 Adds New Twist to Old Favorites 23441 3The Henry H Kessler Foundation Appoints New Vice President for Research and Strengthens Relationship With Current Research Luminary 23436 1The Henry H Kessler Foundation Appoints New Vice President for Research and Strengthens Relationship With Current Research Luminary 23436 2FDA Approves EOVIST 28R 29 to Detect and Characterize Focal Liver Lesions 6412 1FDA Approves EOVIST 28R 29 to Detect and Characterize Focal Liver Lesions 6412 2FDA Approves EOVIST 28R 29 to Detect and Characterize Focal Liver Lesions 6412 3FDA Approves EOVIST 28R 29 to Detect and Characterize Focal Liver Lesions 6412 4FDA Approves EOVIST 28R 29 to Detect and Characterize Focal Liver Lesions 6412 5FDA Approves EOVIST 28R 29 to Detect and Characterize Focal Liver Lesions 6412 6FDA Approves EOVIST 28R 29 to Detect and Characterize Focal Liver Lesions 6412 7MIGENIX Corporate Update and Requisition of Special Meeting 6407 1MIGENIX Corporate Update and Requisition of Special Meeting 6407 2MIGENIX Corporate Update and Requisition of Special Meeting 6407 3MIGENIX Corporate Update and Requisition of Special Meeting 6407 4MIGENIX Corporate Update and Requisition of Special Meeting 6407 5MIGENIX Corporate Update and Requisition of Special Meeting 6407 6MIGENIX Corporate Update and Requisition of Special Meeting 6407 7MIGENIX Corporate Update and Requisition of Special Meeting 6407 8
... is a characteristic of diverse species of birds, ... what circumstances it proves useful have remained...that strongly suggest that for some birds head bob...sual world, despite the motion of their bodies, an...s such as food items. , The motion associated with...
...or human exercise? According an article published ...ake,s eating habits make it a prime model of cardi...ty to adapt to altered physiological requirements,...snake may provide insights into how remodeling of ... and in response to some diseases. , The python do...
...nic stem cell lines specifically tailored to match...es of various ages, suffering from disease or spin...by the journal Science, which is published by AAAS...xpress website on 19 May, 2005. , These cell lines...n the laboratory. The work also moves scientists o...
...xed blessings for scientists who follow research i...onducted by scientists from Cincinnati Children,s ...ol and Hamburg University in Germany, reveals impo...forming stem cells regenerate. On the other hand, ...fects associated with genetic engineering of stem ...
Other Biology News:Bobbing birds do it for a reason 2Scientists generate patient-specific stem cells, Science study says 2Scientists generate patient-specific stem cells, Science study says 3Scientists generate patient-specific stem cells, Science study says 4Science study holds implications for gene therapy and stem cell biology 2Science study holds implications for gene therapy and stem cell biology 3
I-Ab MHC Class II
...orporates the critical design features demanded by...marker research. The Series 4000 delivers improved...rting biomarker discoveries to biomarker assays al...d to fit into the research plans of any life scien...
BssH II Bacillus stearothermophilus from Sigma-Aldrich
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,369-4) or contact custom
Biology Products: